GLOBAL DIAGNOSTICS LABS
A high-complexity CLIA and CAP-certified, service provider laboratory.
As a company, we have a clear focus to improve early detection of cervical disease and prevent cervical cancer with our Proofer 7 HPV-mRNA E6 and E7 Biomarker Test. We carefully focus on the needs of patients and users, by continued innovation and application of new technology.
At the end of 2023 Global Diagnostics Labs, LLC became a wholly owned subsidiary of Mel-Mont Medical, Inc
At Global Diagnostics Labs, we provide testing of cervical samples for HPV-mRNA E6 and E7 oncoproteins. HPV is the virus that is required for a woman to develop cervical cancer. Most women will have an HPV infection throughout their lifetime, but this is usually cleared by the body’s own immune system. It is the women who have infections of certain HPV types that are of concern, as these types are known to contribute towards cell changes, the first step on the road to cervical cancer.
This differs from an HPV DNA test that is available to some women in the national screening programme.
HPV DNA test
HPV mRNA test
HPV mRNA test
Over the past 5 years we have been completing a project with Universitetssykehuset Nord-Norge to test over 100,000 samples to prove the ability of our test in helping women to avoid cervical cancer.
Proofer 7 HPV-mRNA E6 and E7 Biomarker Test.
can be carried out on the same smear sample taken during a routine check-up with your clinician.
For any enquiries, or for more information, please use the form provided through the button.